TY  - JOUR
AU  - Rosenstock, Julio
AU  - Guerci, Bruno
AU  - Hanefeld, Markolf
AU  - Gentile, Sandro
AU  - Aronson, Ronnie
AU  - Tinahones, Francisco J
AU  - Roy-Duval, Christine
AU  - Souhami, Elisabeth
AU  - Wardecki, Marek
AU  - Ye, Jenny
AU  - Perfetti, Riccardo
AU  - Heller, Simon
AU  - GetGoal Duo-2 Trial Investigators
PY  - 2016
DO  - 10.2337/dc16-0014
UR  - http://hdl.handle.net/10668/10120
T2  - Diabetes care
AB  - To provide evidence-based options on how to intensify basal insulin, we explored head-to-head prandial interventions in overweight patients with type 2 diabetes inadequately controlled on basal insulin glargine with or without 1-3 oral antidiabetic...
LA  - en
KW  - Aged
KW  - Blood Glucose
KW  - Body Mass Index
KW  - Body Weight
KW  - Diabetes Mellitus, Type 2
KW  - Drug Therapy, Combination
KW  - Endpoint Determination
KW  - Female
KW  - Glucagon-Like Peptide-1 Receptor
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemia
KW  - Hypoglycemic Agents
KW  - Insulin Glargine
KW  - Male
KW  - Meals
KW  - Metformin
KW  - Middle Aged
KW  - Overweight
KW  - Peptides
KW  - Postprandial Period
TI  - Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.
TY  - research article
VL  - 39
ER  -